An observational study in Infant, Preterm, Respiratory Distress Syndrome (Neonatal) and Chronic Lung Disease of Newborn, sponsored by University of Zurich. Recruiting at 1 site in Switzerland. Open to participants aged Up to 4 Weeks. Per ClinicalTrials.gov, last updated 2025-12-09.
Sponsored by University of Zurich · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 34 studies in Premature Birth with a site in Switzerland — 12 open to participants now, 14 under way, none of them phase 3. Premature Birth · Switzerland.
Among the 34 studies in Premature Birth with a site in Switzerland, this one is the 14th largest by planned enrollment of the 14 observational ones that give a count, is one of 4 that started in 2025, is one of 14 observational ones, reaches primary completion later than 10 of the 13 other live ones, and was the 31st registered.
2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.
Browse Premature Birth studies →12 of the 34 studies in Premature Birth with a site in Switzerland are open now. Recruiting first, the newest first:
Rea Diagnostics SA · Sites in Switzerland
Ages 18+ · Women only
Riccardo Pfister · Sites in Switzerland
Ages 14 days–14 days · Healthy volunteers
Henner Hanssen · Sites in Switzerland
Ages 6–12 · Healthy volunteers
Insel Gruppe AG, University Hospital Bern · Sites in Switzerland
Healthy volunteers
University Hospital, Geneva · Sites in Switzerland
Ages 35 wk–1 yrs · Healthy volunteers
A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →
Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.
This study: Up to 4 Weeks · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
34 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 27 is below the median of 120 across 809 observational studies indexed under Premature Birth.
Median enrollment 57 across the 20 interventional studies, 168 across the 14 observational. Of the 19 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 34 have an industry lead sponsor. The 10 most frequent:
University of Zurich is the lead sponsor of 1,051 studies on the registry; 134 are open to participants now.
University of Zurich has 7 studies filed under Premature Birth — fewer than ten, so there is no comparison to draw.
2 of the studies in Premature Birth with a site in Switzerland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07237139University of ZurichPulmonary Volume Changes During Synchonized Noninvasive Positive Pressure Ventilation | 2026-12-31 |
| NCT07307365Rea Diagnostics SAEvaluation of the Clinical Performance of the PremaSure Kit to Assess Premature Delivery Risk in Symptomatic Pregnant Patients | 2027-03 |
Add all 2 to your calendar (.ics) → With an account.
Among the 34 studies in Premature Birth with a site in Switzerland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Current evidence suggests that noninvasive positive pressure ventilation (NIPPV) is more effective than continuous positive airway pressure (CPAP) in preventing respiratory failure in preterm infants with respiratory distress syndrome (RDS), both as initial and post-extubation support. NIPPV may be delivered in synchronized (sNIPPV) or non-synchronized (nsNIPPV) modes, with sNIPPV offering clear benefits by coordinating support with the infant's own breathing. Recent studies indicate sNIPPV is superior to nsNIPPV in preventing respiratory failure, though the intrapulmonary mechanisms behind this advantage remain unclear. To address this, the present study uses Electrical Impedance Tomography (EIT) to evaluate how lung volume changes during different types of breaths and ventilator inflations - spontaneous breaths, synchronized inflations, non-synchronized inflations, and backup inflations - in preterm infants receiving sNIPPV.
Hypothesis:
Synchronized inflations during NIPPV will increase tidal volumes (VT) and lung aeration when compared with non-synchronized inflations. Pressure peaks delivered during expiration (non-synchronized inflations), between spontaneous breaths (backup inflations), or during periods of apnea (backup inflations) will not increase relative VT.
Primary objective:
The primary objective is to assess lung volume changes between spontaneous breaths and synchronized inflations, non-synchronized inflations, and backup inflations using EIT.
Secondary objectives:
The secondary objectives are to assess regional differences in aeration and ventilation among spontaneous breaths, synchronized inflations, non-synchronized inflations, and backup inflations using EIT.
Primary endpoint:
Difference in relative Vt (rel. Delta-Z) between spontaneous breaths and synchronized inflations.
Study procedures:
Study procedures include attaching an EIT belt and a pulse oximeter sensor during the final nursing care session before the study begins. Synchronized NIPPV is provided by EVEneo ventilators, and synchronization will be achieved through an abdominal capsule (Graseby).
This study will take place at the Department of Neonatology of the University Hospital Zurich. Preterm infants on a synchronized mode of non-invasive positive pressure ventilation will be screened for eligibility and parents will be approached by the treating physician or a clinician-researcher who is authorized to access the patient's clinical data.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Infants on sNIPPV respiratory support and below 4 weeks chronological age
Device: Electrical Impedance Tomography (EIT)
Electrical Impedance Tomography and clinical data will be recorded continuously. Corresponding data will be extracted and analyzed at five pre-defined timepoints.
Tidal volume (VT)
Difference in relative VT (rel. ΔZ) between spontaneous breaths and synchronized inflations.
Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.
Global lung impedance
Difference between end-expiratory lung impedance (EELI) and inspiratory onset lung impedance (SILI) during spontaneous breaths, synchronized inflations, non-synchronized inflations, and back-up inflations.
Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.
Regional tidal volume distribution
Difference in regional tidal distribution between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations
Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.
Center of ventilation
Difference in center of ventilation between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations
Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.
Silent spaces
Difference in silent spaces between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations
Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.
Global inhomogeneity index
Difference in global inhomogeneity index between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations. An inhomogeneity index of zero represents a perfectly homogeneous distribution of ventilation.
Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.
Coefficient of variation
Difference in coefficient of variation (EIT) between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations
Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.
Inspiratory time
Difference in inspiratory times between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations
Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.
Expiratory time
Difference in expiratory times between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations
Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.
Lung ultrasound score
Difference in lung ultrasound score at two pre-defined timepoints. Each lung will be divided into 3 areas. For each lung area, a 0- to 3-point score will be given (total score ranging from 0-18). Higher scores represent greater severity of lung disease.
Time frame: Immediately before the first infant handling as well as following electrical impedance tomography belt removal.
Heart rate
Changes of heart rate between five pre-defined time points.
Time frame: Continuous measurement during the 180-minute recording period.
Peripheral oxygen saturation
Changes in oxygen saturation between five pre-defined time points.
Time frame: Continuous measurement during the 180-minute recording period.
Oxygen supplementation
Changes in FiO2 between five pre-defined time points.
Time frame: Continuous measurement during the 180-minute recording period.
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2025 (actual). Primary completion is estimated for Dec 2026, 13 months after the start.
Of 373 non-industry observational studies under Premature Birth, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 63. This study's planned 13 months is below that.
Counting every sponsor, half of 388 studies reached it within 35 months; a quarter within 19 and three quarters within 61.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.